Tuesday, November 10, 2015
- 9:00AM-11:00AM
-
Abstract Number: 2982
Blood Perfusion in Different Skin Areas of Hands in Primary Raynaud’s Phenomenon and Systemic Sclerosis Patients
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III- 9:00AM-11:00AM
-
Abstract Number: 2238
Body Mass Index Modulates the Relationship Between Sugar-Sweetened Beverage Intake and Serum Urate Concentration
Epidemiology and Public Health Poster III (ACR): Gout and Non-Inflammatory Musculoskeletal Conditions- 9:00AM-11:00AM
-
Abstract Number: 2800
Bone Microarchitecture and Bone Strength in Patients with Primary Sjögren’s Syndrome: A Case-Control Study Using HR-pQCT
Sjögren's Syndrome: Translational Insights into Sjögren's Syndrome- 9:00AM-11:00AM
-
Abstract Number: 2228
Brief Educational Intervention Improves Gout Patients’ Understanding of Their Disease
Education Poster II- 9:00AM-11:00AM
-
Abstract Number: 3016
Bromodomain Inhibitor JQ1 Modulates Smooth Muscle Cell Switching and Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension in Mice
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II- 9:00AM-11:00AM
-
Abstract Number: 3051
Bronchial Artery Enlargement May Cause Recurring Hemoptysis in Behçet’s Syndrome Patients with Pulmonary Artery Involvement Despite Response to Treatment
Vasculitis Poster III- 9:00AM-11:00AM
-
Abstract Number: 3052
Budd-Chiari Syndrome in Behçet’s Disease:a Retrospective Multicenter Study
Vasculitis Poster III- 9:00AM-11:00AM
-
Abstract Number: 2906
Can Immunosuppressive Drug Treatment Reduce Mortality in Patients with Systemic Lupus Erythematosus (SLE): A Propensity Score Analysis of a Longitudinal Cohort of 803 Patients?
Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III- 9:00AM-11:00AM
-
Abstract Number: 2234
Can the Fracture Risk Assessment Tool (FRAX) Also Predict Falls in Older Women?
Epidemiology and Public Health Poster III (ACR): Gout and Non-Inflammatory Musculoskeletal Conditions- 9:00AM-11:00AM
-
Abstract Number: 3057
Can We Differentiate Takayasu’s Arteritis from Atherosclerosis Using Carotid Artery Doppler Usg?
Vasculitis Poster III- 9:00AM-11:00AM
-
Abstract Number: 2347
Can We Predict the Dose of Allopurinol to Achieve Target Urate?
Metabolic and Crystal Arthropathies Poster II- 9:00AM-11:00AM
-
Abstract Number: 2345
Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Long-Term Safety and Efficacy Results from a 36-Week Extension Study
Metabolic and Crystal Arthropathies Poster II- 9:00AM-11:00AM
-
Abstract Number: 2255
Capillaroscopic Patterns in a Healthy Population
Epidemiology and Public Health Poster III (ACR): Gout and Non-Inflammatory Musculoskeletal Conditions- 9:00AM-11:00AM
-
Abstract Number: 2586
Cardiac Magnetic Resonance Imaging Reveals Myocardial Damage in Patients with Active Rheumatoid Arthritis
Rheumatoid Arthritis - Clinical Aspects Poster Session III- 9:00AM-11:00AM
-
Abstract Number: 3064
Cardiac Manifestation of Takayasu Arteritis